Can science take the STING out of runaway inflammation?

by Cincinnati Children's Hospital Medical CenterGraphical abstract. Credit:Cell Reportsand Cincinnati Children'sUntil the COVID-19 pandemic exploded, few people outside of res

Updated on: January 29,2024

Can science take the STING out of runaway inflammation?

by Cincinnati Children's Hospital Medical CenterGraphical abstract. Credit:Cell Reportsand Cincinnati Children'sUntil the COVID-19 pandemic exploded, few people outside of res

Updated on:January 29,2024

Osteoarthritis biomarker could help cut $23 billion health bill

by Candy Gibson,University of South AustraliaCredit: Pixabay/CC0 Public DomainUniversity of South Australia researchers are a step closer to finding a new biomarker for osteoarthritis, a painful

Updated on: May 13,2024

Osteoarthritis biomarker could help cut $23 billion health bill

by Candy Gibson,University of South AustraliaCredit: Pixabay/CC0 Public DomainUniversity of South Australia researchers are a step closer to finding a new biomarker for osteoarthritis, a painful

Updated on:May 13,2024

Study examines the course of back pain over time

by WileyCredit: CC0 Public DomainBack pain is among the most frequently reported health problems in the world. New research published inArthritis Care & Research, an official journal of

Updated on: June 01,2024

Study examines the course of back pain over time

by WileyCredit: CC0 Public DomainBack pain is among the most frequently reported health problems in the world. New research published inArthritis Care & Research, an official journal of

Updated on:June 01,2024

CRISPR screen identifies new anti-inflammatory drug target

by Vanderbilt University Medical CenterCredit: CC0 Public DomainA metabolic enzyme that has been studied in cancer biology and is important for T cell function may offer a new target for anti-inf

Updated on: April 12,2024

CRISPR screen identifies new anti-inflammatory drug target

by Vanderbilt University Medical CenterCredit: CC0 Public DomainA metabolic enzyme that has been studied in cancer biology and is important for T cell function may offer a new target for anti-inf

Updated on:April 12,2024

Updated guidelines released for management of atopic dermatitis

by Elana GotkineIn updated guidelines issued by the American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology, and published online Dec. 17 in theAnna

Updated on: January 26,2024

Updated guidelines released for management of atopic dermatitis

by Elana GotkineIn updated guidelines issued by the American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology, and published online Dec. 17 in theAnna

Updated on:January 26,2024

Research explores environmental pollutant BPA and asthma susceptibility in mice

by PNAS NexusTransmission electron microscopy images demonstrating the effects of BPA on E. coli LPS. Credit: Wang et al.The "hygiene hypothesis" posits that allergic asthma can be triggered

Updated on: January 28,2024

Research explores environmental pollutant BPA and asthma susceptibility in mice

by PNAS NexusTransmission electron microscopy images demonstrating the effects of BPA on E. coli LPS. Credit: Wang et al.The "hygiene hypothesis" posits that allergic asthma can be triggered

Updated on:January 28,2024

Study reveals way to predict side-effect risk from common immune suppressant medication

by University of NottinghamMethotrexate (MTX) is an anti-metabolite most commonly used in chemotherapy and immunosuppressant in auto-immune diseases. Credit: University of NottinghamA major new s

Updated on: January 29,2024

Study reveals way to predict side-effect risk from common immune suppressant medication

by University of NottinghamMethotrexate (MTX) is an anti-metabolite most commonly used in chemotherapy and immunosuppressant in auto-immune diseases. Credit: University of NottinghamA major new s

Updated on:January 29,2024

SRC-3 is a novel regulator of human immune T regulatory cells

by Baylor College of MedicineSuzanne Judd, Ph.D., an epidemiologist at UAB, explains what will lead to herd immunity and why it is important to remain vigilant in reducing the spread of COVID-19.

Updated on: April 22,2024

SRC-3 is a novel regulator of human immune T regulatory cells

by Baylor College of MedicineSuzanne Judd, Ph.D., an epidemiologist at UAB, explains what will lead to herd immunity and why it is important to remain vigilant in reducing the spread of COVID-19.

Updated on:April 22,2024

Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

by American College of RheumatologyDipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these

Updated on: April 07,2024

Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

by American College of RheumatologyDipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these

Updated on:April 07,2024

Study pinpoints optimal timing for RSV vaccine during pregnancy

Updated on: November 14,2024

Study pinpoints optimal timing for RSV vaccine during pregnancy

Updated on:November 14,2024

The double face of RNase as a treatment for systemic autoimmune diseases

by Osaka UniversityThe RNA-degrading enzyme enhances the function of immune complexes formed by autoantibodies against Ro/SSA and La/SSB antigens. Credit: Ryota Naito et al. JCI Insight 2023Syste

Updated on: April 22,2024

The double face of RNase as a treatment for systemic autoimmune diseases

by Osaka UniversityThe RNA-degrading enzyme enhances the function of immune complexes formed by autoantibodies against Ro/SSA and La/SSB antigens. Credit: Ryota Naito et al. JCI Insight 2023Syste

Updated on:April 22,2024

VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

byAmerican Thoracic SocietyCredit: CC0 Public DomainResults from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages

Updated on: March 02,2024

VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

byAmerican Thoracic SocietyCredit: CC0 Public DomainResults from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages

Updated on:March 02,2024